How Orthofix paid its current, former executives

Orthofix’s new CEO Massimo Calafiore started his new role Jan. 8 with an annual base salary of $825,000, according to the company’s April 29 proxy statement.

Advertisement

Along with his salary Mr. Calafiore has a target bonus of 110% of salary and target long-term incentives of $4 million, the proxy statement said. He also received sign-on equity incentive awards of $3.5 million.

CFO Julie Andrews was appointed Jan. 15 with a base salary of $475,000, a target bonus of 70% of salary and target long-term incentives of $1.8 million. 

Chief Legal Officer Andres Cedrón was appointed April 15 with a base salary of $470,000, a target bonus of 70% of salary and target long-term incentives of $1.5 million.

Mr. Calafiore, Ms. Andrews and Mr. Cedrón replaced former CEO Keith Valentine, former CFO John Bostjancic and former Chief Legal Officer Patrick Keran. 

In 2023, Mr. Valentine earned a total compensation of $6.5 million. Mr. Bostjancic and Mr. Keran both earned $1.8 million in total compensation in 2023.

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Is ambulatory care healthcare’s big margin engine? 4 leaders weigh in

Wednesday, July 29
1:00 PM - 2:00 PM CDT

Presenters: Joe Ganley, athenahealthJeffrey Flynn, CASC, Gramercy Surgery CenterBryan Tsao, Access Center, Loma Linda University HealthJason Zepeda, Northridge Hospital Medical Center, CommonSpirit HealthGreg DeConciliis, PA-C, CASC, Boston Out­Patient Surgical Suites

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.